Interim results of the phase 3 CARDINAL study long-term follow-up: Inhibition of complement C1s with sutimlimab in patients with Cold Agglutinin Disease (CAD)A. Roeth,W. Barcellini,S. D'Sa,Y. Miyakawa,C. Broome,M. Michel,D. Kuter,B. Jilma,T. H. A. Tvedt,I. C. Weitz,P. Patel,X. Jiang,C. Reuter,J. Su,F. Shafer,M. Lee,W. Hobbs,S. BerentsenBLOOD（2021）引用 2|浏览30暂无评分摘要Introduction更多查看译文AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
